https://www.targetedonc.com/view/biomarker-testing-in-patients-with-er-her2--mbc
0
0
Biomarker Testing in Patients With ER+/HER2- mBC - Targeted Oncology
10/31/22 at 12:10pm
Organization
Targetedonc.com
Authors
Aditya Bardia MD MPH
Details
42 words
Summarize
Health Cancer Pharmaceuticals & Biotech ER+ Bardia HER2- mBC HER- mBC
Dr Bardia talks about the role of biomarker testing and provides an overview of factors which may contribute to a clinician’s choice of treatment strategy for patients with ER+/HER- mBC.
Create an account or login to join the discussion